Advanced search
Publication Cover
International Journal of Hyperthermia Volume 35, 2018 - Issue 1
Submit an article Journal homepage
3,121
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)

Olivia Le SauxMedical oncology department, Hospices Civils de Lyon, Université de Lyon, Lyon, France; Correspondence[email protected]
View further author information
,
Evelyne DecullierPôle IMER, Hospices Civils de Lyon, Lyon, France; View further author information
,
Gilles FreyerMedical oncology department, Hospices Civils de Lyon, Université de Lyon, Lyon, France; View further author information
,
Olivier GlehenDepartment of General and Digestive Surgery, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, FranceView further author information
&
Naoual BakrinDepartment of General and Digestive Surgery, Centre Hospitalier Lyon Sud, Lyon 1 University, Lyon, FranceView further author information
Pages 652-657 | Received 29 Dec 2017, Accepted 29 Aug 2018, Published online: 08 Oct 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eelco de Bree & Dimosthenis Michelakis. (2020) An overview and update of hyperthermic intraperitoneal chemotherapy in ovarian cancer. Expert Opinion on Pharmacotherapy 21:12, pages 1479-1492.
Read now

Articles from other publishers (14)

Shu-Li Yang, Li-Hui Si, Rui-Xin Lin, Shi-Yu Gu, Jia-Hui Li, Jun-Ze Cui, Chu-Han Yan, Abdulkarim Mohamed Farah & Yan Jia. (2023) Prognostic role of the peritoneal cancer index in ovarian cancer patients who undergo cytoreductive surgery: a meta-analysis. Current Problems in Cancer 47:6, pages 101014.
Crossref
Dong Yang, Yanbin Zhang, Ping Gong, Feiran Liu, Yale Gan & Wenpei Bai. (2023) A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer. Journal of Obstetrics and Gynaecology Research 49:7, pages 1795-1804.
Crossref
Aditi Bhatt, Snita Sinukumar, Vahan Kepenekian, Praveen Kammar, Sanket Mehta, Sakina Shaikh, Witold Gertych, Naoual Bakrin & Olivier Glehen. (2022) Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer. Frontiers in Oncology 12.
Crossref
Miklos Acs, Zoltan Herold, Attila Marcell Szasz, Max Mayr, Sebastian Häusler & Pompiliu Piso. (2022) Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Cancers 14:14, pages 3301.
Crossref
Xiaoli He, Li Wei, Rui Li, Shuang Jing, Linlin Jia, Danwei Ji, Yali Li, Yue Wang & Yongxia Zhu. (2021) Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: a retrospective study. BMC Cancer 21:1.
Crossref
A. Pinto & D. Goéré. (2021) Trattamento chirurgico curativo delle carcinosi peritoneali. EMC - Tecniche Chirurgiche Addominale 27:3, pages 1-12.
Crossref
A. Pinto & D. Goéré. (2021) Tratamiento quirúrgico de la carcinomatosis peritoneal con fines curativos. EMC - Técnicas Quirúrgicas - Aparato Digestivo 37:3, pages 1-13.
Crossref
Daniele Marrelli, Roberto Petrioli, Dario Cassetti, Alessia D'Ignazio, Stefania Marsili, Maria Antonietta Mazzei, Stefano Lazzi & Franco Roviello. (2021) A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer. Surgical Oncology 37, pages 101523.
Crossref
Jyoutishman Saikia, Babul Bansal, SVS Deo, Navin Kumar, Raghuram Kuppusamy, Areendam Barua & MD Ray. (2021) Hyperthermic intraperitoneal chemotherapy in locally advanced and recurrent ovarian carcinoma: surgical and oncological outcomes in the Indian public healthcare system. Future Oncology 17:14, pages 1761-1776.
Crossref
John Spiliotis, Christos Iavazzo, Alexandros Fotiou, Nikolaos Kopanakis, Alexios Terra, Elias Efstathiou, Charalambia Margari & Marinos Tsiatas. (2020) Upfront or intermediate treatment of advanced ovarian cancer patients with cytoreduction plus HIPEC: Results of a retrospective study. Journal of Surgical Oncology 123:2, pages 630-637.
Crossref
Ali Ayhan & Huseyin Akilli. (2020) Prognostic factors associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer. International Journal of Gynecology & Obstetrics 152:2, pages 202-207.
Crossref
Kristjan Ukegjini, Paul Martin Putora, Marisa Guidi, Krisztian Süveg, Nikola Cihoric, Bernhard Widmann & Thomas Steffen. (2021) Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases. Oncology 99:9, pages 601-610.
Crossref
Feifan Xie, Jan Van Bocxlaer, Pieter Colin, Charlotte Carlier, Olivier Van Kerschaver, Joseph Weerts, Hannelore Denys, Philippe Tummers, Wouter Willaert, Wim Ceelen & An Vermeulen. (2020) PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy. The AAPS Journal 22:5.
Crossref
Mohammad Alyami, Martin Hübner, Fabian Grass, Naoual Bakrin, Laurent Villeneuve, Nathalie Laplace, Guillaume Passot, Olivier Glehen & Vahan Kepenekian. (2019) Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. The Lancet Oncology 20:7, pages e368-e377.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.